论文部分内容阅读
回顾分析2017年1月至2020年3月在郑州大学附属洛阳中心医院住院行急诊经皮冠状动脉介入治疗（PCI）的655例急性ST段抬高型心肌梗死（STEMI）患者临床资料。依据首诊机构是否为具有PCI资质的医院，分为首诊PCI医院组（425例）和转诊PCI医院组（230例）。与首诊PCI医院组相比，转诊PCI医院组STEMI患者发病首诊时间较短［2.0（0.8，4.2）h比2.5（1.2，4.1）h，n Z=3.66，n P<0.01］，首次医疗接触至球囊扩张（FMC2B）时间［175（113，344）min比75（57，112）min，n Z=-8.92，n P<0.01］较长，总缺血时间［5.4（3.5，9.8）h比 3.9（2.4，6.0）h，n Z=-5.43，n P<0.01］较长。两组PCI医院入门至球囊扩张（DTB）时间［43（29，103）min比46（61，94）min，n Z=-0.56，n P=0.573］差异无统计学意义。转诊PCI医院组FMC2B时间<120 min的达标率仅为25.9%（50/193）。首诊机构对心力衰竭（n OR=0.54，95n %CI=0.16~1.79，n P=0.311）及死亡风险（n OR=1.14，95n %CI：0.20~6.36，n P=0.885）无影响。结果提示转诊PCI医院的STEMI患者存在转诊延迟，FMC2B时间<120 min的达标率较低。n “,”Clinical data of 655 patients with acute ST-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) in Luoyang Central Hospital during January 2017 to March 2020 were analyzed retrospectively. There were 425 cases who first visited PCI-capable hospital (PCI hospital group) and 230 cases who were transferred to PCI-capable hospital (transfer group). Compared with PCI hospital group, STEMI patients in the transfer group had a shorter first diagnosis time [2.0 (0.8, 4.2)h n vs. 2.5(1.2, 4.1)h, n Z=3.66, n P<0.01], longer time from first medical contact to the balloon through (FMC2B) [175 (113, 344) min n vs. 75 (57, 112) min, n Z=-8.92, n P<0.01], longer total ischemic time [5.4 (3.5, 9.8) h n vs. 3.9 (2.4, 6.0) h, n Z=-5.43, n P<0.01]. There was no significant difference in the time from PCI hospital entry to balloon passage (DTB) between the two groups [43(29, 103) min n vs. 46 (61, 94) min, n Z=-0.56, n P=0.573]. The compliance rate of FMC2B time<120 min in the transfer group was only 25.9% (50/193). However, the different first-visit hospital had no significant effect on the risk of heart failure (n OR=0.54, 95n %CI:0.16-1.79, n P=0.311) and risk of death (n OR=1.14, 95n %CI:0.20-6.36, n P=0.885). The results suggest that STEMI patients referred to PCI hospitals have considerable time delay, and the rate of compliance with FMC2B time<120 min is low.n